Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, Jenburkt Pharmaceuticals has informed about intimation regarding loss of share certificate(s) received on 29th July, 2024, as details enclosed.
The above information is a part of company’s filings submitted to BSE.